Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - A series of allyl molybdenum [(η3-C3H5)Mo(CO)2L2Cl], [(η3-C3H4COOMe)Mo(CO)2L2Br], cyclopentadienyl molybdenum [(η5-C5H4R)Mo(CO)2L2][BF4] (R = H, 4-MeOC6H4CH2, 3,4,5-(MeO)3C6H2CH2), indenyl molybdenum [(η5-C9H6R)Mo(CO)2L2][BF4] (R = H, 4-MeOC6H4CH2) and cyclopentadienyl tungsten compounds [(η5-C5H5)W(CO)2L2][BF4], where L2 is N,N'-chelating ligand, were synthesized and characterized. The in vitro assay on human leukemia cells MOLT-4 has shown that the substitution in the π-ligand has lower effect of on cytotoxicity than exchange of the N,N'-chelating ligand. Nevertheless, even this modification can lead to considerable enhance of cytotoxicity as was evidenced on the series of the indenyl molybdenum(II) compounds.
- A series of allyl molybdenum [(η3-C3H5)Mo(CO)2L2Cl], [(η3-C3H4COOMe)Mo(CO)2L2Br], cyclopentadienyl molybdenum [(η5-C5H4R)Mo(CO)2L2][BF4] (R = H, 4-MeOC6H4CH2, 3,4,5-(MeO)3C6H2CH2), indenyl molybdenum [(η5-C9H6R)Mo(CO)2L2][BF4] (R = H, 4-MeOC6H4CH2) and cyclopentadienyl tungsten compounds [(η5-C5H5)W(CO)2L2][BF4], where L2 is N,N'-chelating ligand, were synthesized and characterized. The in vitro assay on human leukemia cells MOLT-4 has shown that the substitution in the π-ligand has lower effect of on cytotoxicity than exchange of the N,N'-chelating ligand. Nevertheless, even this modification can lead to considerable enhance of cytotoxicity as was evidenced on the series of the indenyl molybdenum(II) compounds. (en)
|
Title
| - The effect of substitution on the cytotoxicity of molybdenum(II) and tungsten(II) compounds
- The effect of substitution on the cytotoxicity of molybdenum(II) and tungsten(II) compounds (en)
|
skos:prefLabel
| - The effect of substitution on the cytotoxicity of molybdenum(II) and tungsten(II) compounds
- The effect of substitution on the cytotoxicity of molybdenum(II) and tungsten(II) compounds (en)
|
skos:notation
| - RIV/00216208:11150/12:10124994!RIV13-MSM-11150___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11150/12:10124994
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Leukemia therapy; Cytotoxicity; X-ray diffraction; Indenyl; Cyclopentadienyl; Molybdenum (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Organometallic Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Padělková, Zdeňka
- Vinklárek, Jaromír
- Řezáčová, Martina
- Honzíček, Jan
- Foltánová, Karolína
- Šebestová, Lucie
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1016/j.jorganchem.2012.07.011
|
http://localhost/t...ganizacniJednotka
| |